Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children

Brain and Development

Volumn 33, Issue 3, 2011, Pages 189-194

  Visudtibhan, Anannit ^a   Bhudhisawadi, Kasama ^a   Vaewpanich, Jarin ^a   Chulavatnatol, Suvatna ^b   Kaojareon, Sming ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Children; Intravenous infusion; Pharmacokinetics; Thailand; Valproate

Indexed keywords

VALPROIC ACID;

ADOLESCENT; AMMONIA BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; EPILEPTIC STATE; FEMALE; HUMAN; LIVER FUNCTION TEST; MALE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; AMMONIA; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HALF-LIFE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; RECURRENCE; SEIZURES; STATUS EPILEPTICUS; THAILAND; VALPROIC ACID;

EID: 79251610651     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.04.003     Document Type: Article

References (39)

1. Wheless J.W., Clarke D.F., Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 2005, 20(Suppl. 1):S1-S56.
2. Trinka E. The use of valproate and new antiepileptic drugs in status epilepticus. Epilepsia 2007, 48(Suppl. 8):49-51.
3. Shorvon S., Baulac M., Cross H., Trinka E., Walker M. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 2008, 49:1277-1285.
4. Lambrechtsen F.A., Buchhalter J.R. Aborted and refractory status epilepticus in children: a comparative analysis. Epilepsia 2008, 49:615-625.
5. Wheless J.W., Vazquez B.R., Kanner A.M., Ramsay R.E., Morton L., Pellock J.M. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004, 63:1507-1508.
6. Visudtibhan A., Limhirun J., Chiemchanya S., Visudhiphan P. Convulsive status epilepticus in Thai children at Ramathibodi Hospital. J Med Assoc Thai 2006, 89:803-808.
7. Sugai K. Treatment of convulsive status epilepticus in infants and young children in Japan. Acta Neurol Scand 2007, 186(Suppl.):62-70.
8. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339:792-798.
9. Giroud M., Dumas R. Pharmacokinetics of valproate in adults after a single loading dose. Arch Neurol 1989, 46:13-14.
10. Devinsky O., Leppik I., Willmore L.J., Pellock J.M., Dean C., Gates J., et al. Safety of intravenous valproate. Ann Neurol 1995, 38:670-674.
11. Naritoku D.K., Mueed S. Intravenous loading of valproate for epilepsy. Clin Neuropharmacol 1999, 22:102-106.
12. Ramsay R.E., Cantrell D., Collins S.D., Walch J.K., Naritoku D.K., Cloyd J.C., et al. Safety and tolerance of rapidly infused Depacon. A randomized trial in subjects with epilepsy. Epilepsy Res 2003, 52:189-201.
13. Peters C.N., Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus - experience in 102 adult patients. Seizure 2005, 14:164-169.
14. Limdi N.A., Knowlton R.K., Cofield S.S., Ver Hoef L.W., Paige A.L., Dutta S., et al. Safety of rapid intravenous loading of valproate. Epilepsia 2007, 48:478-483.
15. Cloyd J.C., Fischer J.H., Kriel R.L., Kraus D.M. Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin Pharmacol Ther 1993, 53:22-29.
16. Birnbaum A.K., Kriel R.L., Norberg S.K., Wical B.S., Le D.N., Leppik I.E., et al. Rapid infusion of sodium valproate in acutely ill children. Pediatr Neurol 2003, 28:300-303.
17. Kanner A.M. The pharmacology of parenteral valproate. Epilepsy Curr 2003, 3:109-111.
18. Mehta V., Singhi P., Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol 2007, 22:1191-1197.
19. Panomvana Na Ayudhya D., Suwanmanee J., Visudtibhan A. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. Am J Ther 2006, 13:211-217.
20. Campistol J., Fernandez A., Ortega J. Status epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines. Rev Neurol 1999, 29:359-365.
21. Chez M.G., Hammer M.S., Loeffel M., Nowinski C., Bagan B.T. Clinical experience of three pediatric and one adult case of spike-and-wave status epilepticus treated with injectable valproic acid. J Child Neurol 1999, 14:239-242.
22. Hovinga C.A., Chicella M.F., Rose D.F., Eades S.K., Dalton J.T., Phelps S.J. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother 1999, 33:579-584.
23. Alfonso I., Alvarez L.A., Gilman J., Dunoyer C., Yelin K., Papazian O. Intravenous valproate dosing in neonates. J Child Neurol 2000, 15:827-829.
24. Uberall M.A., Trollmann R., Wunsiedler U., Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 2000, 54:2188-2189.
25. Yu K.T., Mills S., Thompson N., Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 2003, 44:724-726.
26. Morton L.D., O'Hara K.A., Coots B.P., Pellock J.M. Safety of rapid intravenous valproate infusion in pediatric patients. Pediatr Neurol 2007, 36:81-83.
27. Taylor L.M., Farzam F., Cook A.M., Lewis D.A., Baumann R.J., Kuhn R.J. Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients. Pharmacotherapy 2007, 27:519-525.
28. Aldenkamp A., Vigevano F., Arzimanoglou A., Covanis A. Role of valproate across the ages. Treatment of epilepsy in children. Acta Neurol Scand 2006, 184(Suppl.):1-13.
29. Nitsche V., Mascher H. The pharmacokinetics of valproic acid after oral and parenteral administration in healthy volunteers. Epilepsia 1982, 23:153-162.
30. Zaccara G., Messori A., Moroni F. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1988, 15:367-389.
31. Park H.M., Kang S.S., Lee Y.B., Shin D.J., Kim O.N., Lee S.B., et al. Population pharmacokinetics of intravenous valproic acid in Korean patients. J Clin Pharm Ther 2002, 27:419-425.
32. Misra U.K., Kalita J., Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006, 67:340-342.
33. Cloyd J.C., Dutta S., Cao G., Walch J.K., Collins S.D., Granneman G.R. Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy. Epilepsy Res 2003, 53:19-27.
34. Kriel R.L., Fischer J.H., Cloyd J.C., Green K.H., Fraser G.L. Valproic acid pharmacokinetics in children: III. Very high dosage requirements. Pediatr Neurol 1986, 2:202-208.
35. Embacher N., Karner E., Wanschitz J., Beer R., Trinka E. Acute encephalopathy after intravenous administration of valproate in non-convulsive status epilepticus. Eur J Neurol 2006, 13:e5-e6.
36. White J.R., Santos C.S. Intravenous valproate associated with significant hypotension in the treatment of status epilepticus. J Child Neurol 1999, 14:822-823.
37. Dutta S., Cloyd J.C., Granneman G.R., Collins S.D. Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation. Epilepsy Res 2003, 53:29-38.
38. Goraya J.S., Khurana D.S., Valencia I., Melvin J.J., Cruz M., Legido A., et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol 2008, 38:177-180.
39. Kellinghaus C., Berning S., Besselmann M. Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009, 14:429-431.